Vemurafenib is a First-in-class B-RAF Inhibitor for Melanoma Research
v-Raf murine sarcoma viral oncogene homolog B (BRAF) is the part of the mitogen-activated protein kinase (MAPK) signaling pathway. BRAF was first discovered in 2002. The discovery of BRAF mutations…